Free Trial

Telomir Pharmaceuticals (TELO) Earnings Date, Estimates & Call Transcripts

Telomir Pharmaceuticals logo
$2.10 -0.10 (-4.55%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$2.13 +0.03 (+1.43%)
As of 05/23/2025 04:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Telomir Pharmaceuticals Earnings Summary

Telomir Pharmaceuticals released Q1 2025 earnings on May 12, 2025, reporting an EPS of -$0.07, which beat the consensus estimate of -$0.10 by $0.03. With a trailing EPS of -$0.42, Telomir Pharmaceuticals' earnings are expected to grow next year, from ($0.40) to ($0.36) per share.

Q1 2025 Earnings Resources

TELO Upcoming Earnings

Telomir Pharmaceuticals' next earnings date is estimated for Tuesday, August 12, 2025, based on past reporting schedules.

Upcoming Q2
Earnings Date
Aug. 12Estimated
Consensus EPS
(May. 12)
-$0.10
Actual EPS
(May. 12)
-$0.07 Beat By $0.03
Get Telomir Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Telomir Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

TELO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Telomir Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.10-$0.10-$0.10
Q2 20251-$0.10-$0.10-$0.10
Q3 20251-$0.10-$0.10-$0.10
Q4 20251-$0.10-$0.10-$0.10
FY 2025 4 -$0.40 -$0.40 -$0.40
Q1 20261-$0.09-$0.09-$0.09
Q2 20261-$0.10-$0.10-$0.10
Q3 20261-$0.08-$0.08-$0.08
Q4 20261-$0.09-$0.09-$0.09

Telomir Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/12/2025
(Estimated)
--------
5/12/2025Q1 2025-$0.10-$0.07+$0.03-$0.07--
2/4/2025Q4 2024-$0.05-$0.10 -$0.05-$0.10--
11/12/2024---$0.20 -$0.20-$0.20--
8/13/2024Q2 2024--$0.05 -$0.05-$0.05--
5/13/2024Q1 2024--$0.23 -$0.23-$0.23--

Telomir Pharmaceuticals Earnings - Frequently Asked Questions

Telomir Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on TELO's earnings history.

In the previous quarter, Telomir Pharmaceuticals (NASDAQ:TELO) reported ($0.07) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.10) by $0.03. Learn more on analysts' earnings estimate vs. TELO's actual earnings.

Telomir Pharmaceuticals (NASDAQ:TELO) has a recorded net income of -$16.53 million. TELO has generated -$0.42 earnings per share over the last four quarters.

Telomir Pharmaceuticals's earnings are expected to grow from ($0.40) per share to ($0.36) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:TELO) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners